Treatments for Psychogenic Nonepileptic Seizures (NES)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The investigators propose that treatment of the comorbid disorders (depression, anxiety, and
impulsivity) with sertraline in patients with lone psychogenic nonepileptic seizures (NES),
will result in a decreased number of NES. The purpose of this study is to provide pilot
testing and data to inform the future randomized controlled trial based on the hypothesis.
Phase:
Phase 4
Details
Lead Sponsor:
Rhode Island Hospital
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)